Sort   by:  
 Page size 
UnknownApplication of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
Not available
S-EPMC7217941 | biostudies-literature
UnknownHER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
Not available
S-EPMC9482930 | biostudies-literature
UnknownFrequency and management of maternal infection in health facilities in 52 countries (GLOSS): a 1-week inception cohort study.
Not available
S-EPMC7196885 | biostudies-literature
UnknownAvailability of facility resources and services and infection-related maternal outcomes in the WHO Global Maternal Sepsis Study: a cross-sectional study.
Not available
S-EPMC8370881 | biostudies-literature
UnknownPitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Not available
S-EPMC7217863 | biostudies-literature
Sort   by:  
 Page size